We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.4B
AUM Growth
+$1.5B
Cap. Flow
+$1.66B
Cap. Flow %
7.75%
Top 10 Hldgs %
50.4%
Holding
201
New
31
Increased
27
Reduced
32
Closed
37

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.41B
2
CHTR icon
Charter Communications
CHTR
+$462M
3
CBRE icon
CBRE Group
CBRE
+$375M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$314M
5
VMW
VMware, Inc
VMW
+$285M

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$249M
2
IQV icon
IQVIA
IQV
+$239M
3
BIIB icon
Biogen
BIIB
+$172M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$130M
5
TMO icon
Thermo Fisher Scientific
TMO
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 31.13%
2 Technology 23.99%
3 Financials 9.09%
4 Communication Services 6.05%
5 Industrials 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOW icon
26
ServiceNow
NOW
$129B
$267M 1.25%
2,387,750
-97,500
-4% -$11.1M
BSX icon
27
Boston Scientific
BSX
$71.5B
$266M 1.24%
5,039,257
-6,000
-0.1% -$315K
MA icon
28
Mastercard
MA
$493B
$240M 1.12%
606,471
-178,300
-23% -$71.6M
BX icon
29
Blackstone
BX
$110B
$239M 1.11%
2,227,051
-831,200
-27% -$86.6M
HWM icon
30
Howmet Aerospace
HWM
$112B
$220M 1.02%
4,747,627
-1,110,000
-19% -$54.1M
AON icon
31
Aon
AON
$76B
$216M 1.01%
665,661
-162,125
-20% -$53.6M
CSGP icon
32
CoStar Group
CSGP
$12.3B
$214M 1%
2,786,856
+35,800
+1% +$2.97M
HUM icon
33
Humana
HUM
$46.2B
$177M 0.83%
364,461
+106,000
+41% +$49.8M
V icon
34
Visa
V
$677B
$175M 0.82%
761,410
-277,900
-27% -$66.8M
SRPT icon
35
Sarepta Therapeutics
SRPT
$1.77B
$167M 0.78%
1,375,200
+170,000
+14% +$19.2M
ELV icon
36
Elevance Health
ELV
$85.5B
$166M 0.77%
381,330
-64,000
-14% -$29M
LNTH icon
37
Lantheus
LNTH
$6.59B
$111M 0.52%
1,598,500
+238,000
+17% +$17.4M
BEAM icon
38
Beam Therapeutics
BEAM
$2.84B
$108M 0.5%
4,481,839
+1,040,317
+30% +$27.9M
CI icon
39
Cigna
CI
$74.6B
$105M 0.49%
366,000
+148,000
+68% +$42.2M
XYZ
40
Block Inc
XYZ
$47.5B
$103M 0.48%
2,336,350
-1,007,700
-30% -$62.4M
NTRA icon
41
Natera
NTRA
$46.4B
$101M 0.47%
2,277,883
+953,700
+72% +$48.6M
RVMD icon
42
Revolution Medicines
RVMD
$44B
$92M 0.43%
3,325,480
+542,000
+19% +$16.1M
PTGX icon
43
Protagonist Therapeutics
PTGX
$9.44B
$90.8M 0.42%
5,446,430
+935,000
+21% +$18.1M
PACB icon
44
Pacific Biosciences
PACB
$370M
$85.4M 0.4%
10,224,120
+1,886,000
+23% +$21.6M
INSP icon
45
Inspire Medical Systems
INSP
$1.74B
$84.6M 0.39%
426,096
+103,000
+32% +$26M
BABA icon
46
Alibaba
BABA
$308B
$74.8M 0.35%
862,233
-1,007,767
-54% -$92.2M
BEKE icon
47
KE Holdings
BEKE
$18.8B
$73.9M 0.34%
4,758,500
– –
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$126B
$70.2M 0.33%
+202,000
New +$70.6M
PCG icon
49
PG&E
PCG
$38.5B
$68.1M 0.32%
4,221,642
-783,500
-16% -$13.5M
AGIO icon
50
Agios Pharmaceuticals
AGIO
$1.93B
$68.1M 0.32%
2,750,829
+62,000
+2% +$1.64M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Farallon Capital Management held 201 positions worth $21.4B, up 7.5% from $19.9B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Farallon Capital Management deployed $1.66B of net new capital in Q3 2023, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Charter Communications: 1,111,341 shares worth $489M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was IQVIA, an estimated $239M trimmed.

  • Farallon Capital Management's largest Q3 2023 buy was Charter Communications: 1,111,341 shares worth $489M.
  • Farallon Capital Management added most to Activision Blizzard in Q3 2023, an estimated $1.41B increase.
  • Farallon Capital Management's biggest Q3 2023 reduction was IQVIA, cutting an estimated $239M.
  • Farallon Capital Management fully exited Equifax in Q3 2023, selling an estimated $249M.
  • Farallon Capital Management's ten largest holdings make up 50% of its $21.4B portfolio in Q3 2023.
  • Farallon Capital Management opened 31 new positions and closed 37 in Q3 2023.
  • Farallon Capital Management's portfolio value rose 7.5% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.